Example: [Collected via e-mail, 2003]
October 2, 2003
Risks of FluMist Vaccine
An Investigation By Dr. Sherri Tenpenny
MedImmune, the manufacturer of FluMist, recently announced that it signed an agreement that makes FluMist, the new intranasal influenza vaccine, readily available to people as they shop at
As the physician in charge of a bustling Integrative medical clinic, questions about vaccines frequently arise. After reading about the MedImmune-Walmart joint venture, I felt compelled to warn our patients and our internet subscribers of the potentially serious complications that may come from direct and passive exposure to this new vaccine. I also wanted to give a "heads up" to everyone regarding the onslaught of advertising that is about to besiege them.
Hundreds of TV and print advertisements have been designed to persuade everyone into taking the FluMist plunge. The campaign will be the "most intense, direct-to-consumer marketing campaign ever waged for a vaccine," costing an estimated
[The rest of the article can be found on
Origins: Although influenza is no longer the unchecked grim reaper of years past (in 1918 it killed half a million Americans and twenty million folks worldwide), it continues to present a very real danger even in these more modern times. According to the Centers for Disease Control (CDC), millions of people in the United States
Some people are more vulnerable to the ravages of the flu than others, which is why those who are most at risk need to be shielded from its contagion. Folks
Cost, inconvenience, and dread of injection keep people from availing themselves of this preventive. The stumbling blocks of cost and inconvenience are being eroded, however: the price of a flu shot is down to $17, and
Aversion to needles explains the appeal of vaccines that are sprayed into the nose: do away with the needle, and more people will choose to guard themselves from the flu. FluMist, a nasally-delivered spray, requires one squirt per nostril of a very fine mist to accomplish what an injection does, and every bit as effectively. There are
But these are minor concerns compared to the more troubling aspects of this new form of medicine. Flu shots are made from killed flu viruses and are suitable for anyone
But even for the healthy
The live virus can be transmitted to others by way of coughing, sneezing, or talking, or via a fomite, an item touched by someone who has the virus. (Common cold, flu, and stomach viruses can live on the fingertips for hours, and they can survive on the surfaces of objects for days.) However, says the CDC: "Because the viruses are weakened, infection is unlikely to result in influenza illness symptoms since the vaccine viruses have not been shown to mutate into typical or naturally occurring influenza viruses."
Others in the medical field consider Dr. Tenpenny's analysis more alarmist than practical. For example, she writes:
It is true FluMist's manufacturer, MedImmune Vaccines, and its marketer, Wyeth Vaccines, have been advertising the intranasal vaccine heavily, especially in television ads. They've a product to sell, and they're intent upon selling it. But it can also be reasonably concluded that the availability of a non-injected flu vaccine will motivate many who would otherwise have gone unprotected to guard themselves against a disease that kills. People do fear needles, and their trepidation influences them to delay or entirely eschew vaccination. Take away the needle, and more will seek out the vaccine.
Some sources suggest FluMist will result in a protection against the flu virus that will last far longer than the protection imparted by injected vaccines, but this claim has yet to be fully substantiated. However, if this does prove to be the case, it would become a strong argument in the favor of the nasally-delivered protectant, because a traditional flu vaccination given in October can lose its effectiveness by March, leaving its host vulnerable to infection. The buzz about FluMist suggests its protection will last a full year. (Repeated vaccinations are necessary to protect against new strains of the flu, and because the body's immunity to the flu declines over time.)
There is a risk that a small number of those who avail themselves of the intranasal vaccine will pass the live virus used in it to others, but is there not a far greater danger presented by those whose fear of needles keeps them from getting vaccinated? They catch the flu, and they pass it to others, with the contagion so transmitted living on through their victims to infect even more. Vaccine, no matter how delivered, can stop the spread of virus.
Barbara "marriage does not have to mean 'What's mine is yours'" Mikkelson
Update: As of mid-November 2003, MedImmune had sold only 400,000 doses of FluMist and estimated that 50 to
|Preventing Influenza (Centers for Disease Control)|
| FluMist |
(MedImmune Vaccines, Inc.)
Long, Kim and Terry Reim. Fatal Facts. New York: Arlington House, 1985. ISBN 0-517-63216-0 (pp. 33-35). Marchione, Marilynn. "Inhaled Flu Vaccine Not Shot in Arm for Disease Fight." Milwaukee Journal Sentinel. 6 October 2003 (p. G1). Olson, Elizabeth. "An Option for the Needle-Shy: Spray Flu Vaccine." The New York Times. 4 November 2003 (p. D6). Pollack, Andrew. "Anatomy of a Failed Product Introduction." The New York Times. 19 November 2003 (p. C9). Roan, Shari. "Flu Shot Gave You the Flu? It's a Myth." Los Angeles Times. 3 November 2003 (p. F1). Snowbeck, Christopher. "Some Hesitate on New Flu Mist." Pittsburgh Post-Gazette. 15 September 2003 (p. A1). Tierno, Philip. The Secret Life of Germs. New York: Pocket Books, 2001. ISBN 0-7434-2187-6 (pp. 50, 89, 99). Reuters. "Wal-Mart Won't Offer Nasal-Spray Flu Vaccine." The New York Times. 18 October 2003 (p. C4). The Washington Post. "Clearing the FluMist." 30 September 2003 (p. F2).